Authors: Beall, HD Sloan, KB

Citation: Hd. Beall et Kb. Sloan, Topical delivery of 5-fluorouracil (5-FU) by 3-alkylcarbonyl-5-FU prodrugs, INT J PHARM, 217(1-2), 2001, pp. 127-137

Authors: Roberts, WJ Sloan, KB

Citation: Wj. Roberts et Kb. Sloan, Application of the transformed Potts-Guy equation to in vivo human skin data, J PHARM SCI, 90(9), 2001, pp. 1318-1323

Authors: Sloan, KB DellaVecchia, SA Estes, JV Roberts, WJ

Citation: Kb. Sloan et al., 7-alkylcarbonyl and 7-alkyloxycarbonyl prodrugs of theophylline, INT J PHARM, 205(1-2), 2000, pp. 53-63

Authors: Roberts, WJ Sloan, KB

Citation: Wj. Roberts et Kb. Sloan, Prediction of transdermal flux of prodrugs of 5-fluorouracil, theophylline, and 6-mercaptopurine with a series/parallel model, J PHARM SCI, 89(11), 2000, pp. 1415-1431

Authors: Roberts, WJ Sloan, KB

Citation: Wj. Roberts et Kb. Sloan, Correlation of aqueous and lipid solubilities with flux for prodrugs of 5-fluorouracil, theophylline, and 6-mercaptopurine: A Potts-Guy approach, J PHARM SCI, 88(5), 1999, pp. 515-522

Authors: Caram, L Doeleman, M Roberts, WJ Prankerd, RJ Perrin, JH Underberg, WJ Sloan, KB

Citation: L. Caram et al., Synthesis of 1- and 3-arylcarbonyl derivatives of 5-fluorouracil, J HETERO CH, 36(2), 1999, pp. 397-401